Spots Global Cancer Trial Database for biphosphonates
Every month we try and update this database with for biphosphonates cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer | NCT00415779 | Metastatic Pros... | docetaxel zoledronic acid | 18 Years - | National Cancer Institute, Naples | |
IFM 99-02 Thalidomide in Myeloma | NCT00222053 | Multiple Myelom... | Thalidomide Biphosphonates | 18 Years - 65 Years | University Hospital, Toulouse | |
ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer | NCT00415779 | Metastatic Pros... | docetaxel zoledronic acid | 18 Years - | National Cancer Institute, Naples |